Bristol-Myers Squibb Co (BSP:BMYB34) Cyclically Adjusted Book per Share: R$78.19 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:BMYB34 Bristol-Myers Squibb Co BSP:BMYB34
71 GF Score
Price R$349.41
GF Value R$291.42
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Bristol-Myers Squibb Co Cyclically Adjusted Book per Share?

Bristol-Myers Squibb Co BSP:BMYB34 71 Cyclically Adjusted Book per Share is R$78.19 as of Jun. 2026. GuruFocus rates BSP:BMYB34 with a GF Score™ of 71/100 and a GF Value™ of R$291.42 (Modestly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Bristol-Myers Squibb Co's adjusted book value per share for the three months ended in Jun. 2026 was R$55.987. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is R$78.19 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Bristol-Myers Squibb Co's average Cyclically Adjusted Book Growth Rate was 1.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 2.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 5.30% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Bristol-Myers Squibb Co was 10.80% per year. The lowest was 2.10% per year. And the median was 5.40% per year.

As of today (2026-08-29), Bristol-Myers Squibb Co's current stock price is R$349.41. Bristol-Myers Squibb Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was R$78.19. Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio of today is 4.47.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bristol-Myers Squibb Co was 7.54. The lowest was 2.70. And the median was 5.30.


Bristol-Myers Squibb Co  (BSP:BMYB34) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=349.41/78.19
=4.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bristol-Myers Squibb Co was 7.54. The lowest was 2.70. And the median was 5.30.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Bristol-Myers Squibb Co Cyclically Adjusted Book per Share Related Terms


Bristol-Myers Squibb Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Bristol-Myers Squibb Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bristol-Myers Squibb Co Cyclically Adjusted Book per Share Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 70.44 72.76 70.91 92.45 81.44

Bristol-Myers Squibb Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.46 78.55 81.44 75.65 78.19

BSP:BMYB34 vs PFE, GILD, AMGN: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio falls into.


BSP:BMYB34
71GF Score
Bristol-Myers Squibb Co BSP:BMYB34
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bristol-Myers Squibb Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bristol-Myers Squibb Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=55.987/333.9520*333.9520
=55.987

Current CPI (Jun. 2026) = 333.9520.

Bristol-Myers Squibb Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 30.392 241.428 42.039
201612 32.607 241.432 45.102
201703 27.367 243.801 37.487
201706 29.537 244.955 40.268
201709 28.293 246.819 38.281
201712 23.807 246.524 32.250
201803 25.664 249.554 34.343
201806 28.463 251.989 37.721
201809 34.336 252.439 45.423
201812 33.552 251.233 44.599
201903 35.732 254.202 46.942
201906 37.829 256.143 49.320
201909 44.621 256.759 58.036
201912 95.056 256.974 123.531
202003 107.781 258.115 139.448
202006 113.011 257.797 146.395
202009 119.860 260.280 153.786
202012 87.610 260.474 112.324
202103 94.905 264.877 119.654
202106 83.294 271.696 102.380
202109 88.504 274.310 107.747
202112 94.413 278.802 113.089
202203 73.814 287.504 85.739
202206 77.075 296.311 86.866
202209 80.574 296.808 90.657
202212 78.519 296.797 88.349
202303 78.933 301.836 87.332
202306 74.288 305.109 81.311
202309 70.409 307.789 76.394
202312 71.351 306.746 77.679
202403 40.512 312.332 43.316
202406 45.212 314.175 48.058
202409 46.800 315.301 49.568
202412 49.118 315.605 51.973
202503 49.195 319.799 51.372
202506 47.514 322.561 49.192
202509 48.857 324.800 50.234
202512 49.507 324.054 51.019
202603 51.401 330.213 51.983
202606 55.987 333.952 55.987

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of R$78.19 mean?
Bristol-Myers Squibb Co (BSP:BMYB34) has a Cyclically Adjusted Book per Share of R$78.19 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bristol-Myers Squibb Co and its competitors.
Is Bristol-Myers Squibb Co's Cyclically Adjusted Book per Share too high?
Bristol-Myers Squibb Co's current Cyclically Adjusted Book per Share is R$78.19. Overall, Bristol-Myers Squibb Co has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bristol-Myers Squibb Co's Cyclically Adjusted Book per Share compare to PFE and GILD?
Bristol-Myers Squibb Co's Cyclically Adjusted Book per Share of R$78.19 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bristol-Myers Squibb Co and its competitors. Bristol-Myers Squibb Co's current Cyclically Adjusted Book per Share is R$78.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bristol-Myers Squibb Co stock overvalued right now?
Based on GuruFocus' analysis, Bristol-Myers Squibb Co (BSP:BMYB34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$291.42, compared to a current price of R$349.41 — trading 19.9% above its estimated fair value. The current Cyclically Adjusted Book per Share is R$78.19. Bristol-Myers Squibb Co's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Bristol-Myers Squibb Co (BSP:BMYB34), the current Cyclically Adjusted Book per Share is R$78.19 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bristol-Myers Squibb Co (BSP:BMYB34) Overvalued in 2026?

Based on GuruFocus' analysis, Bristol-Myers Squibb Co stock appears to be overvalued. The current stock price of R$349.41 is trading 19.9% above its estimated GF Value™ of R$291.42. GuruFocus considers Bristol-Myers Squibb Co to be Modestly Overvalued.

Key valuation signals for BSP:BMYB34:

  • Cyclically Adjusted Book per Share: R$78.19
  • GF Value™: R$291.42 vs. price of R$349.41 (19.9% above fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the BSP:BMYB34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bristol-Myers Squibb Co Business Description

Address Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
71GF Score

Get the complete analysis for BSP:BMYB34

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$349.41
Price
R$291.42
GF Value